ImmunityBio (IBRX) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -13.32% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 17.12% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -10.19% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 24.11% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 12.18% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.92% |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | -16.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.62% |
| Dec 31, 2025 | -16.65% |
| Sep 30, 2025 | -6.96% |
| Jun 30, 2025 | -6.31% |
| Mar 31, 2025 | -5.75% |
| Dec 31, 2024 | -6.15% |
| Sep 30, 2024 | -8.37% |
| Jun 30, 2024 | -6.29% |
| Mar 31, 2024 | -6.91% |
| Dec 31, 2023 | 1.69% |
| Sep 30, 2023 | 16.53% |
| Jun 30, 2023 | 26.83% |
| Mar 31, 2023 | 46.52% |
| Dec 31, 2022 | 73.37% |
| Sep 30, 2022 | 86.67% |
| Jun 30, 2022 | 34.17% |
| Mar 31, 2022 | 30.10% |
| Dec 31, 2021 | 14.23% |
| Sep 30, 2021 | 25.09% |
| Jun 30, 2021 | 51.88% |
| Mar 31, 2021 | 38.16% |
| Dec 31, 2020 | 19.90% |
| Sep 30, 2020 | -10.12% |
| Jun 30, 2020 | -9.95% |
| Mar 31, 2020 | -13.81% |
| Dec 31, 2019 | -21.31% |
| Sep 30, 2019 | -19.56% |
| Jun 30, 2019 | -16.78% |
| Mar 31, 2019 | -11.59% |
| Dec 31, 2018 | 0.21% |
| Sep 30, 2018 | 3.76% |
| Jun 30, 2018 | 29.88% |
| Mar 31, 2018 | 240.57% |
| Dec 31, 2017 | 305.83% |
| Sep 30, 2017 | 352.02% |
| Jun 30, 2017 | 533.41% |
| Mar 31, 2017 | 215.23% |
| Dec 31, 2016 | 242.31% |
| Sep 30, 2016 | 1,065.13% |
| Jun 30, 2016 | 246.97% |
| Dec 31, 2015 | 2,517.54% |